Líderes de pacientes latinoamericanos consideran innovación y acceso durante COVID-19
Los lideres y advocates de pacientes en América Latina están explorando como las políticas inteligentes pueden fomentar la innovación y proteger el acceso de los pacientes durante COVID-19.
Latin American Advocates Consider Innovation, Access During COVID-19
Patient advocates across Latin America are exploring how smart policy can encourage innovation and protect patient access during COVID-19.
Latin America Leads the Way on Telemedicine
As the COVID-19 pandemic drives a global telemedicine revolution, one Latin American initiative is proving the value of remote care.
What the World Can Do About Genetic High Cholesterol
This month’s JAMA Cardiology features an international call to action from the global community impacted by familial hypercholesterolemia, or FH.
Biosimilar Briefings Review Nature and Impact of Biosimilars on Access
Physicians across Latin America are coming together to discuss a timely topic: what access to biosimilars means to their patients.
Survey Highlights Desire for Innovation in Latin America
Central and South American governments should consider new policies that support innovation in health care and improve patient access, according to results from a survey recently conducted by the Global Alliance for Patient Access.
Encuesta destaca el deseo de impulsar innovación en América Latina
Según los resultados de una encuesta realizada recientemente por la Alianza Global para el Acceso de Pacientes, los gobiernos de América Central y América del Sur deben considerar nuevas políticas que apoyen la innovación en la atención médica y mejoren el acceso a los pacientes.
GAfPA’s Statement Supporting the USMCA Signing at the G20 Summit
A new international treaty has important implications for patients’ access to innovative treatments. On November 30, during the G20 Summit in Buenos Aires Argentina, President Trump, Prime Minister Trudeau and President Peña Nieto signed the new U.S. Mexico Canada Agreement. Once approved by the U.S. Congress, this trade deal will replace NAFTA as the free […]
GAfPA Statement on United States-Mexico-Canada Agreement
Patients who are eager for the next generation of treatments and cures will be well served by the United States-Mexico-Canada Agreement. This agreement provides intellectual property protections that promote patient access to innovative medicine, clearing the way for new treatments for cancer, Alzheimer’s, diabetes and many other conditions.
La farmacovigilancia como modo de reforzamiento de regulaciones
El viernes 24 de agosto de 2018 se llevó a cabo el primer webinario de la Academia Latinoamericana de Pacientes. La academia tuvo su primera reunión en la ciudad de Miami el 26 de mayo. Este webinario sirvió como un seguimiento de esa reunión. El tema del webinario enfocaba en la farmacovigilancia como modo de […]
